Our Expertise

The global pharmaceutical market has changed significantly in the past few years. There is a move away from the era of mass-market block-buster products into a more complex world which focuses on large molecules, more niche markets, personalised medicine and is driven by a more complex buying process.

We believe it is critical to formulate a broad understanding of the different interactions of stakeholders in the healthcare system to really understand where the points of leverage or leakage are. All too often different stakeholders provide different perceptions of key issues, such as reasons for adherence. If the research programme only focuses on one stakeholder perspective (usually physicians) then true market understanding and the ability to change perceptions can be lost.

We combine our in-depth knowledge of different healthcare structures with framework approaches to research issues. We also believe that the patient is an important stakeholder in the assessment of any particular therapy area. They provide a more holistic view of the market dynamic and can help to identify priority stages in the healthcare system.

Add this page as a favourite.Add to My Ipsos MORI Bookmark and share this page.Bookmark & Share Email this page.Send this page by email Print this page.Print this page

contact us

Contact Us



Hilary WortonHilary Worton
Head of Health
Email



Lucy BennettLucy Bennett
Director
Email



Emily PeasgoodEmily Peasgood
Director
Email

curved border.

Our Stakeholder Model

Click here to view the wide range of stakeholders we work with.

Read MoreRead More

curved border.